Mode 1 and Mode 2 Analysis of Graphite/Epoxy Composites Using Double Cantilever Beam and End-Notched Flexure Tests

The critical strain energy release rates associated with debonding of the adhesive bondlines in graphite/epoxy IM6/3501-6 interlaminar fracture specimens were investigated. Two panels were manufactured for this investigation; however, panel two was layed-up incorrectly. As a result, data collected from Panel Two serves no real purpose in this investigation. Double Cantilever Beam (DCB) specimens were used to determine the opening Mode I interlaminar fracture toughness, G1(sub c), of uni-directional fiber re-inforced composites. The five specimens tested from Panel One had an average value of 946.42J/sq m for G1(sub c) with an acceptable coefficient of variation. The critical strain energy release rate, G2(sub c), for initiation of delamination under inplane shear loading was investigated using the End-Notched Flexure (ENF) Test. Four specimens were tested from Panel One and an average value of 584.98J/sq m for G2(sub c) was calculated. Calculations from the DCB and ENF test results for Panel One represent typical values of G1(sub c) and G2(sub c) for the adhesive debonding in the material studied in this investigation

American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus

10.1002/acr.23834ARTHRITIS CARE & RESEARCH715579-59

American college of rheumatology provisional criteria for clinically relevant improvement in children and adolescents with childhood-onset systemic Lupus erythematosus

To develop a Childhood Lupus Improvement Index (CHILI) as a tool to measure response to therapy in childhood-onset systemic lupus erythematosus (cSLE), with a focus on clinically relevant improvement (CRIcSLE). Methods Pediatric nephrology and rheumatology subspecialists (n = 213) experienced in cSLE management were invited to define CRIcSLE and rate a total of 433 unique patient profiles for the presence/absence of CRIcSLE. Patient profiles included the following cSLE core response variables (CRVs): global assessment of patient well-being (patient-global), physician assessment of cSLE activity (MD-global), disease activity index score (here, we used the Systemic Lupus Erythematosus Disease Activity Index), urine protein-to-creatinine ratio, and Child Health Questionnaire physical summary score. Percentage and absolute changes in these cSLE-CRVs (baseline versus follow-up) were considered in order to develop candidate algorithms and validate their performance (sensitivity, specificity, area under the receiver operating characteristic curve [AUC]; range 0-1). Results During an international consensus conference, unanimous agreement on a definition of CRIcSLE was achieved; cSLE experts (n = 13) concurred (100%) that the preferred CHILI algorithm considers absolute changes in the cSLE-CRVs. After transformation to a range of 0-100, a CHILI score of >= 54 had outstanding accuracy for identifying CRIcSLE (AUC 0.93, sensitivity 81.1%, and specificity 84.2%). CHILI scores also reflect minor, moderate, and major improvement for values exceeding 15, 68, and 92, respectively (all AUC >= 0.92, sensitivity >= 93.1%, and specificity >= 73.4%). Conclusion The CHILI is a new, seemingly highly accurate index for measuring CRI in cSLE over time. This index is useful to categorize the degree of response to therapy in children and adolescents with cSLE.715579590CNPQ - Conselho Nacional de Desenvolvimento Científico e TecnológicoFAPESP – Fundação de Amparo à Pesquisa Do Estado De São Paulo303422/2015-7; 7/2016-9; 304255/2015-7215/03756-